Where does Neumora Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neumora Therapeutics, Inc. ranks #15,484 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neumora Therapeutics, Inc. hold?

Neumora Therapeutics, Inc. holds 19 US utility patents granted between 2023 and 2025, spanning 11 technology areas.

What is Neumora Therapeutics, Inc.'s Innovation Score?

Neumora Therapeutics, Inc. has an Innovation Score of 57.1 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Neumora Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Neumora Therapeutics, Inc..

What does claim depth mean for Neumora Therapeutics, Inc.'s patents?

Neumora Therapeutics, Inc.'s patents average 26.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neumora Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neumora Therapeutics, Inc.

Q: What technology areas does Neumora Therapeutics, Inc. focus on?

Neumora Therapeutics, Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 13 patents, ranking #379 of 3,149 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 11 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neumora ranks #15,484 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 11 technology areas.

#15,484
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.1/100): 26.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15484 · US Corporation #15,484 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,484/49,997
PHOTO-FINISH Nail Alliance
CPC-FOCUS G16H · 11 areas
INNOV-PAR 57.1/100
CLAIMS-DENSE 26.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Nail Alliance, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neumora’s 57.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (18%) Velocity 20.0 pts (35%) Breadth 11.7 pts (21%) Claim depth 15.0 pts (26%)

Qualcomm Incorporated · highest

85
Neumora Therapeutics · this assignee

57
3D Lighting… · lowest

7

What this shows Neumora's Innovation Score is 57.1/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neumora?

Each dot is one of Neumora’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neumora’s own 26.8 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neumora vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neumora's grants concentrate

Neumora Therapeutics, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 68.4% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (9 grants) versus a trough of 7 in 2023. By volume, Neumora sits between Nuseed Global Innovation Ltd. and Nextleaf Solutions Ltd..

Neumora's three-year grant acceleration

Neumora Therapeutics, Inc. shows 16 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nuseed Global Inn…

19
Nyse Chicago

19
Nail Alliance

19
Nanohmics

19
Next Level Racing…

19
Nextbit Systems

19
Nextern Innovation

19
Nextleaf Solutions

19
Neumora Therapeut… ◀

19

What this shows Neumora holds 19 patents at rank #15,492, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neumora

By rank, the assignees closest to #15,492 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Neumora's primary technology class.

Neumora's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Neumora Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	7	36.8%
2024	9	47.4%
2025partial year	3	15.8%

Which technologies does Neumora Therapeutics, Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 13

G06V - Image OR Video Recognition OR Understanding 6

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 6

G06N - Computing Arrangements Based ON Specific Computational Models 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C07D - Heterocyclic Compounds 6

G06T - Image Data Processing OR Generation, IN General 5

A61B - DIAGNOSIS; SURGERY; Identification 4

G06F - Electric Digital Data Processing 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neumora Therapeutics, Inc.'s patent record in context - here's where to go next.

Neumora Therapeutics, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 68.4% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #15,484 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neumora Therapeutics, Inc. against Nuseed Global Innovation Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.